Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peramivir vs Oseltamivir in Hospitalized Influenza
NCT00453999Phase 2Completed
- Sponsor
- BioCryst Pharmaceuticals, Inc.
- Start
- Jul 2007
- Primary completion
- Sep 2008
- Modality
- Orthosteric Ligands
- Countries
- 7
01
Overview
Phase 2, randomised, double-blind trial of peramivir in influenza (3 arms), sponsored by BioCryst Pharmaceuticals, Inc. Primary endpoint: Time to Clinical Stability at 14 days. Started Jul 2007; status: completed.
02
Drugs
peramivir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00453999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00453999.